SCHEMBL5804485

SCHEMBL5804485

Cc1cc(CC(=O)NS(=O)(=O)c2ccc(C#N)cc2)n(-c2ccccc2)n1.Cc1cc(CC(=O)NS(=O)(=O)c2ccc(Cl)cc2)n(-c2ccc(F)cc2)n1.Cc1cc(CC(=O)NS(=O)(=O)c2ccc(Cl)cc2)n(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.47
ERBB2 P04626 5/20 0.47
PTGES O14684 8/20 0.47
ALOX5 P09917 8/20 0.47
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
LMNA P02545 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
FPR1 P21462 1/20 0.42
CNR1 P21554 1/20 0.41
CXCR2 P25025 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5805188 0.90 ALDH1A1 (0.46) PTGESALOX5
SCHEMBL5807526 0.89 EGFR (0.58) EGFRERBB2PTGESALOX5LMNA
SCHEMBL5807982 0.88 PTGES (0.56) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5807053 0.83 PTGES (0.52) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5804879 0.82 PTGES (0.51) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5820740 0.81 ALDH1A1 (0.43) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5807553 0.81 EGFR (0.50) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5806852 0.81 ALDH1A1 (0.50) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5808774 0.80 ALDH1A1 (0.59) EGFRERBB2PTGESALOX5MAPK13
SCHEMBL5805227 0.79 EGFR (0.47) EGFRERBB2PTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006075955-A1 PYRAZOLYL ACYLSULFONAMIDE DERIVATIVES AS ENDOTHELIN CONVERTING ENZYME INHIBITORS AND USEFUL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASTRAZENECA AB (SE) 2006-07-20 WO disclosed